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1. Introduction 
The endocrine system is a network of endocrine glands and nerves throughout the body. 
Endocrine glands produce and release hormones that circulate around the body in the 
blood. Hormones keep an even balance of chemicals and fluid within the body, and help us 
respond to changes in the environment. The endocrine system is made up of several glands, 
including the adrenal glands. 
1.1 The adrenal medulla and its hormones 
There are two adrenal glands in our body that produce a number of vital hormones essential 
for survival. The adrenal glands, located at the superior poles of the two kidneys, are 
composed of two distinct layers, the adrenal cortex and the adrenal medulla. The outer 
adrenal cortex, which develops from the abdominal mesothelium, surrounding the medulla 
during embryogenesis, synthesizes and secretes the adrenocortical hormones, the 
mineralocorticoids and glucocorticoids, as well as the adrenogenic (sexual) hormones.  
The adrenal medulla, which comprises the central 20% of the gland, originates from the 
neural crest, and does not become distinct and compact until the adrenal cortex atrophies 
during the first few weeks postnatally. The adrenal medulla is a modified sympathetic 
ganglion which secretes in the bloodstream the catecholamines epinephrine (adrenaline) 
and norepinephrine (noradrenaline) in response to sympathetic neural stimulation to the 
medullae. Depending on the physiological conditions, this secretion averages 80% 
epinephrine to 20% norepinephrine. Although dopamine is present in the adrenal and 
serves as a precursor for norepinephrine and epinephrine, minimal dopamine secretion 
occurs and the role of adrenal dopamine is not well understood.  
Cells of the medulla are known as pheochromocytes or chromaffin cells, referring to the 
dark color produced by the polymerization of oxidized catecholamines when these cells are 
exposed to chromium salts. The early medulla also contains neuroblasts and developing 
sympathetic ganglion cells, but these populations decrease with proliferation and 
maturation of the chromaffin cell population during the first years of life in the human. The 
pheochromocytes are arranged in nests and cords and contain abundant membrane-bound 
dense granules, in which the catecholamines are stored. On stimulation, these granules are 
transported to the cell surface via the microtubular system, and the neurotransmitter 
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contents of the vesicles released by exocytosis. Although circulating epinephrine is derived 
entirely from the adrenal medulla, only about 30% of the circulating norepinephrine comes 
from the medulla. The rest is released from nerve terminals and hence the adrenal medulla 
is not essential for life. 
1.2 Functions of medullary catecholamines 
The physiologic effects of epinephrine and norepinephrine are initiated by their binding to 
adrenergic receptors on the surface of target cells. These receptors are prototypical examples 
of seven-pass transmembrane proteins that are coupled to G proteins which stimulate or 
inhibit intracellular signaling pathways. Complex physiologic responses result from adrenal 
medullary stimulation because there are multiple receptor types which are differentially 
expressed in different tissues and cells. The alpha and beta adrenergic receptors and their 
subtypes were originally defined by differential binding of various agonists/antagonists 
and by analysis of molecular clones.  
In general, circulating epinephrine and norepinephrine released from the adrenal medulla 
have the same effects on target organs as direct stimulation by sympathetic nerves, except 
the effects last five to ten times as long because these neurotransmitter hormones are 
removed too slowly from peripheral circulation. Additionally, of course, circulating 
hormones can cause effects in cells and tissues that are not directly innervated. The 
physiologic consequences of medullary catecholamine release are justifiably framed as 
responses which aid in dealing with stress. These effects are important in helping the body 
to react to emergency situations, thus norepinephrine and epinephrine are sometimes called 
the hormones of “fight or flight”. A listing of some major effects mediated by medullary 
catecholamine are: increased rate and force of contraction of the heart muscle; constriction of 
blood vessels (this causes widespread vasoconstriction, resulting in increased resistance and 
hence arterial blood pressure); dilation of bronchioles (assists in pulmonary ventilation); 
stimulation of lipolysis in fat cells (this provides fatty acids for energy production in many 
tissues and aids in conservation of dwindling reserves of blood glucose); increased 
metabolic rate (oxygen consumption and heat production increase throughout the body as 
well as the breakdown of glycogen in skeletal muscle which provides glucose for energy 
production); dilation of the pupils; inhibition of certain "non-essential" processes: an 
example is inhibition of gastrointestinal secretion and motor activity. Common stimuli for 
secretion of adrenomedullary hormones include exercise, hypoglycemia, hemorrhage and 
emotional distress.  
1.3 Tumours of the adrenal medulla: pheochromocytomas 
A tumour cell is part of a tissue that is abnormally growing. It may be either malignant or 
benign in nature. “Tumour” originally meant “swelling” because, with unchecked cellular 
reproduction, the tissue affected swells to sometimes grotesque proportions. Tumour cells 
that are malignant are generally referred to as cancer cells, and have the ability to 
metastasize, or spread to neighboring tissues and grow tumours there. Benign tumour cells 
do not invade neighboring tissues, but may grow to great size and cause other problems: 
breathing, mobility, circulatory. While a malignant tumour might not be eradicated by 
surgically removing it, a benign tumour generally is. 
Tumours of the adrenal gland can develop in either the cortex or the medulla. Benign 
tumours of the cortex are called adrenal cortical adenomas. Malignant tumours are called 
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adrenal cortical carcinomas. The World Health Organization reserves the term 
pheochromocytoma for tumours arising from chromaffin cells in the adrenal medulla. A 
small number of phaeochromocytomas start outside the medulla part of the adrenal gland 
and are known as extra-adrenal phaeochromocytomas or paragangliomas. A 
pheochromocytoma is an intra-adrenal sympathetic paraganglioma. This arbitrary 
nomenclature emphasizes important distinctive properties of intra-adrenal tumours, 
including an often adrenergic phenotype, relatively low rate of malignancy, and 
predilection to occur in particular hereditary syndromes. Although pheochromocytomas are 
extremely rare in humans, with an annual incidence of less than 1 per million, occult 
germline mutations characteristic of familial syndromes are now found in more than 20% of 
patients with apparently sporadic tumours, bringing the percentage of tumours with a 
known genetic basis close to 30% (Karagiannis et al., 2007). In addition, tumour location and 
risk of malignancy vary with the underlying genetic defect.  
Pheochromocytoma develops as a single tumour or as more than one growth. Only one 
adrenal gland is usually affected. Rarely, tumours affect both adrenal glands; these are 
known as bilateral adrenal tumours. The tumours may occur at any age, but they are most 
common from early to mid-adulthood. In patients with pheochromocytomas, there is a 
release of excessive amounts of catecholamines. If the diagnosis of a pheochromocytoma is 
overlooked, the consequences could be disastrous, even fatal; however, if a 
pheochromocytoma is found, it is potentially curable. Most pheochromocytomas are benign 
(noncancerous), and 90% of cases can be successfully treated by surgery (Petri et al., 2009).  
Many cardiac manifestations are associated with pheochromocytomas. Hypertension is the 
most common complication. Cardiac arrhythmias, such as atrial and ventricular fibrillation, 
may occur because of excessive plasma catecholamine levels. Other complications include 
myocarditis, signs and symptoms of myocardial infarction, dilated cardiomyopathy, and 
pulmonary edema, either of cardiac or noncardiac origin. Different neurologic complications 
may also occur. A pheochromocytoma-induced hypertensive crisis may precipitate 
hypertensive encephalopathy, which is characterized by altered mental status, focal 
neurologic signs and symptoms, or seizures. Other neurologic complications include stroke 
due to cerebral infarction or an embolic event secondary to a mural thrombus from a dilated 
cardiomyopathy. Moreover, intracerebral hemorrhage may origine because of uncontrolled 
hypertension. 
2. Pheochromocytoma cell lines 
Pheochromocytoma cells rapidly cease proliferating in primary culture. In most instances, 
proliferation of neoplastic chromaffin cells ceases with two weeks and does not resume, 
although the cells persist in cultures maintained for many months (Tischler et al., 2004). In 
addition, variable proportions of the tumour cell populations undergo spontaneous 
neuronal differentiation. Propensity for neuronal differentiation may in part reflect 
underlying genetic abnormalities. Establishment of pheochromocytoma cell lines is 
therefore a challenging task. Routinely, different immunocytochemical staining provide a 
means for distinguishing neoplastic chromaffin cells from other cell types in primary 
cultures and for rapidly assessing the success of attempts to establish cell lines (Powers et 
al., 2000).  
The development of experimental applications of animal models of pheochromocytoma has, 
to a large extent, been initially driven by intriguing observations made with human tumour 
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tissue. Individual animal models have subsequently found their own applications, while at 
the same time contributing, in different ways and varying degrees, to understanding of 
human pathology. The rarity of pheochromocytomas is notable across species, with the 
exception of the rat. In some strains of laboratory rats, upwards of 30% of males 
spontaneously develop pheochromocytomas. In contrast, the lifetime frequency of the 
tumours is typically around 1% in wildtype laboratory mice, but much higher in several 
genetically engineered mouse models (Ohta et al., 2006; Tischler et al., 2004). Similarities and 
differences between the rat and mouse models suggest both parallel and unique 
applications for each and also raise questions of which model is more relevant to various 
aspects of human tumour biology. Advantages of the murine models include genetic 
resemblances to human pheochromocytomas (Eaton & Duplan, 2004; Molatore et al., 2010). 
Disadvantages include an apparently less stable phenotype. 
At present, a variety of continuous adrenal medullary cell lines have been established (Eaton 
& Duplan, 2004). Initially, continuous chromaffin cell lines were derived from spontaneous 
pheochromocytoma tumours of the medulla, either from murine (i.e., rat PC12 cells) or 
human sources. In particular, the first continuous cell line derived from a sporadic benign 
human adrenal pheochomocytoma is the KNA cell line (Pfragner et al., 1998) although 
earlier attempts by these same researchers resulted in four similar human cell lines with 
finite lifespans of up to one year in culture. However, there is a heterogeneity among KNA 
subclones. In addition, KNA cells detach early from the tissue culture dish and grow as 
large multicellular spheroids with loose cell-cell adhesion. A similar medullary adrenal cell 
line derived from a human pheochromocytoma is the KAT45 cell line (Venihaki et al., 1998). 
Such cell lines have revealed both the unique characteristics of oncogenic adrenal medullary 
tumours, as well as similarities in catecholamine regulation to normal chromaffin adrenal 
tissue. However, both human cell lines have only provided in vitro data and it is generally 
accepted that there are currently no adequately documented human pheochromocytoma cell 
lines, despite the attempts to establish them.  
Over the last few decades, more sophisticated molecular methods have allowed for induced 
tumourigenesis and targeted oncogenesis in vivo, where isolation of specific populations of 
mouse cell lines of endocrine origin have resulted in model cells to examine a variety of 
regulatory pathways in the chromaffin phenotype (Eaton & Duplan, 2004; Tischler et al., 
2004). Although these cells are attractive experimental models by virtue of their genetic and 
functional similarities to human pheochromocytomas, a drawback compared to other 
models is a greater tendency to phenotype drift. This may in part be due to the same factors 
that cause mouse pheochromocytomas to appear polymorphous in histologic sections or it 
may reflect cell culture artefact. Finally, conditional immortalization with retroviral 
infection of chromaffin precursors has provided homogeneous and expandable chromaffin 
cells in animal models. This same strategy of immortalization with conditionally expressed 
oncogenes has been expanded to create the first disimmortalizable chromaffin cells (Eaton & 
Duplan, 2004). However, these promising lines have not been extensively studied, yet. 
Although the available cell models have already been used for several additional novel 
applications, they are best regarded as complementary systems of human 
pheochromocytomas. Data indicates that caution is warranted in drawing general 
conclusions from any single cell line, but also suggest that understanding of factors that 
permit pheochromocytoma cells to proliferate might itself provide important insights for 
tumour biology. 
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2.1 PC12 cells 
Among chromaffin cell lines, the earliest example is PC12 rat cell line. It was first established 
from a representative rat pheochromocytoma in 1976 (Greene & Tischler, 1976) and has 
become an important workhorse in many disciplines. PC12 cells arose from animals that had 
been irradiated postnatally, probably with resultant genetic damage that permitted the lines 
to be established. The phenotype of the PC12 line has been remarkably stable during almost 
35 years of propagation. However, a somewhat variability of different desired traits has 
occurred in some laboratories, emphasizing the importance of freezing and storing early 
passages of any cell line. The characteristics of the cells have also been affected by culture 
conditions, most notably a switch made in some laboratories early in the history of the cell 
line from RPMI 1640 medium to Dulbecco’s modified Eagle’s medium, which increases cell 
flattening and cell-substratum adhesion.  
The popularity of PC12 cells is mainly because of their extreme versatility for 
pharmacological manipulation, their ease of culture and the large amount of background 
knowledge on their proliferation and differentiation. Like adrenal chromaffin cells, PC12 
cells synthesize and store dopamine and sometimes noradrenaline, which are released upon 
depolarization in a Ca2+-dependent way. A common application of PC12 cells concerns the 
study of the cellular and molecular aspects of cell death, involving normal and neoplastic 
conditions. Also, a notable characteristic of PC12 cells is that they can readily be induced to 
differentiate in culture with the NGF, whereby cells cease to multiply, assume a neurite-
bearing phenotype that resemble mature sympathetic neurons and exhibit firm attachment 
to the substratum.  
3. Apoptosis in pheochromocytoma PC12 cells 
The fate of a cell is determined by a balance of survival or promoting signals. While survival 
signals mediate cell maintenance, promoting signals induce cells to proliferate, differentiate, 
transform or apoptose. The natural occurrence of cell death has long been appreciated and 
was widely studied by nineteenth century biologists. While multiple modes of cell death 
have been described, undoubtedly the most renowned process is the programmed form of 
cell death known as apoptosis. In many diseases, aberrant regulation of apoptosis is the 
central abnormality. For example, resistance of cells to apoptosis is thought to be responsible 
for many types of cancer, while on the other hand in many neurological disorders an 
excessive neuronal death is a central feature.  
As NGF can readily induce PC12 transition from a naïve, actively proliferating to a 
quiescent, differentiated phenotype, the responsiveness to NGF by PC12 cells has allowed 
them to be used for a great variety of studies concerning not only PC12 cells as a purported 
model of adrenal medullary cells, but as a model of neuronal differentiation and 
pluripotency. These features are possessed by primitive progenitors from the medulla which 
can differentiate into either chromaffin cells or sympathetic neurons, depending on the local 
microenvironment.  
A search of the PubMed database in June 2011 yields almost 1800 papers published from 
1990 describing apoptosis in PC12 cells. Indeed, PC12 is considered a suitable and reliable 
model to study (neuro)apoptotic mechanisms as well as for predicting (neuro)cytotoxicity of 
experimental drugs and natural compounds. Although caution is warranted in drawing 
general conclusions from any single cell line, understanding of factors that modulate PC12 
cell proliferation/death might itself provide important insights in cell biology.  
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In this section, we will concentrate on the programmed cell death mechanisms in PC12 cells, 
considering primarily the recent insights achieved in the last years. We will also consider 
these mechanisms under a pharmacological point of view, as for instance in the context of 
(neuro)cytotoxicological studies and/or the developing of promising compounds with 
potential therapeutic applications. 
3.1 Cellular machinery  
Apoptosis, also known as programmed cell death, is characterized by distinctive 
stereotyped morphological and biochemical alterations, such as exposure of 
phosphatidylserine on the outer leaflet of the plasma membrane and blebbing, cell 
shrinkage, chromatin condensation, and DNA fragmentation. This process leads to the 
formation of apoptotic bodies that are subsequently eliminated by phagocytosis. Key event 
in the apoptotic process is the activation of caspases, a family of cysteinyl aspartate-specific 
proteases. They are constitutively expressed in almost all cell types as inactive proenzymes 
(zymogens) that became processed and activated in response to a variety of pro-apoptotic 
stimuli. Evidence for the sequential activation of caspases has lead to the concept of a 
caspase cascade: during apoptosis, apoptogenic stimuli induce the autocatalitically 
activation of initiator caspases; subsequentely they cleave and thereby activate downstream 
effector caspases that carry on the cleavage of specific proteins in order to “dismantle” the 
cell. 
The induction of apoptosis can be mediated by two pathways: the death receptor-dependent 
or the mitochondria-dependent pathways, also known as the extrinsic and intrinsic 
apoptotic pathways, respectively (Jin & El-Deiry, 2005). The extrinsic apoptotic pathway 
begins at the cell surface where death receptors bind their ligands, such TNF family 
members, including FasL (or CD95L). Ligand binding to the death receptor triggers the 
oligomerization of the death receptor and the aggregation of the characteristic intracellular 
motif, known as “death domain” able to recruit adaptor proteins containing death domains, 
such as FADD. These adaptor proteins function to activate initiator caspase-8 and/or 
caspase-10, resulting in the formation of the death-inducing signaling complex. Activated 
initiator caspases in turn process and activate the downstream executioner caspases, 
including caspase-3, -6, and -7, which execute the destruction of the cell (Degterev et al., 
2003). The study of death receptors-induced apoptosis in PC12 cells has been particularly 
important in understanding the pathogenesis of neurodegenerative diseases. For instance, it 
is of interest to note that amyloid ┚ peptide toxicity (a model of Alzheimer disease in vitro, 
see also below) may involve the CD95 pathway while TNF is strictly linked with excitotoxic 
mechanisms. The intrinsic apoptotic pathway involves the mitochondria in response to 
diverse cellular stress such as UV and gamma irradiation, heat and the activation of some 
oncogenic factors. The critical event in the mitochondria-mediated apoptotic pathway is the 
mitochondrial outer membrane permeabilization, that prompts the release of various 
proteins of the mitochondrial intermembrane space into the cytosol. In addition, the 
mitochondrial proteins of Bcl2 family (i.e., Bcl2 and Bax) play a fundamental role as negative 
or positive modulators. Of importance, cytochrome c, released from mitochondria, binds to 
Apaf-1 to form a complex, the “apoptosome,” that recruits procaspase-9 and facilitates its 
oligomerization and activation. Activated caspase-9, in turn, processes and activates the 
executioner caspases-3, -6, and -7, which drive the execution of the cell.  
The homeostasis of healthy tissues is maintained by the survival signaling pathways 
responsible for the control of cell proliferation. In this respect, one of the best-studied 
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mechanism responsible for apoptosis in PC12-derived neurons is the serum or growth factor 
withdrawal leading to the classical apoptosis. In contrast, the best-characterized survival 
pathway in PC12 cells is that involving NGF. NGF belongs to a family of structurally related 
neurotrophin proteins, including BDNF, NT-3, and NT-4/5 that function to support the 
growth and survival of many populations of neurons. NGF binds the TrkA neurotrophin 
receptor, whereas BDNF and NT-4/5 bind the TrkB neurotrophin receptor, and NT-3 
primarily binds the TrkC neurotrophin receptor. These Trk neurotrophin receptors are able 
to protect neuronal cells from apoptosis, and they can stimulate neuronal regeneration in 
different model systems. NGF activates a variety of signaling cascades, including the protein 
kinases ERK1/2 and PI3K-Akt pathways, that are dynamically linked to the apoptotic 
machinery in a complex cellular signaling network. Their activation by survival signals 
serves to block apoptotic signaling. The proto-oncogene protein kinase Raf-MEK-ERK1/2 
pathway is the better characterized Ras (a GTPase) effector pathway that plays a key role in 
PC12 cell proliferation. Once activated, ERK phosphorylates and thereby regulates the 
activities of a number of substrates, including multiple transcription factors inducing 
alteration in gene expression directly linked with the extracellular signal from the cell 
surface receptors and thus preventing apoptosis. It is very recent the discovery that, among 
all the targets of NGF-activated ERK in PC12 cells the two microRNA 221 and 222 are 
involved in NGF-dependent neuronal survival. (Terasawa et al., 2009). In PC12 cells, the 
PI3K-Akt pathway, the other downstream mediator of NGF, includes, among its several 
targets, the FoxO family of transcription factors which play a particularly important role in 
the regulation of cell death, proliferation, and survival through modulation of the 
expression of cell-cycle inhibitory genes and pro-apoptotic genes. The kinase Akt also 
controls the activity of mTORC1, another key mediator of cell growth, proliferation, and 
survival that can function to inhibit PC12 cell apoptosis. 
Another intriguing issue, recently demonstrated in several models including PC12, is that 
cell cycle activation often precedes neuronal death , indicating that neurons attempt to 
divide before dying (Bianco et al., 2011). Multiple pathways and stimuli, including NGF 
deprivation, have been demonstrated to participate in the regulation of cell cycle events 
during death of differentiated PC12. These aspects may have a significant clinical interest. 
Indeed, different papers have reported the re-expression of proteins of the cell cycle in 
neurons from patients with Alzheimer disease, Parkinson’s disease, ataxia telangiectasia, 
stroke, and other neurodegenerative conditions. 
On the other hand, controversial is the use of PC12 as model of apoptotis induced by the 
release of the excitatory neurotransmitter glutamate. For many years PC12 cells have been 
used to investigate NMDA receptor mediated excitotoxicity and potential neuroprotective 
mechanisms (Lee et al., 2006). In a key paper, Casado and coll. (Casado et al., 1996) 
demonstrated an increase in NR1 protein (a NMDA channel subunit) expression levels in 
PC12 cells in response to NGF, and their ability to evoke NMDA and glutamate induced 
currents. However, other studies are not entirely consistent with these results. Among them, 
Edwards and coll. (Edwards et al., 2007) demonstrated the absence of functional NMDA 
receptors in PC12 cells thus suggesting that the mechanism by which NMDA or glutamate 
induces excitotoxicity in PC12 cells cannot be assumed to occurr by direct actions on NMDA 
receptors but, instead, non-NMDA receptor mechanisms, including oxidative stress, may 
drive cytotoxic response to high glutamate concentrations.  
PC12 cells have been also shown to be useful models to characterize the molecular 
mechanisms that determine cellular commitment to cell death following oxygen-derived 
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Fig. 1. Scheme of some apoptotic mechanisms achieved in PC12 cells (GF: Growth factors; 
GFR: GF receptors; Shc/Grb2/Sos: classical protein complex involved in Ras activation). 
free radicals including superoxide, peroxynitrite, peroxyl radicals, and the hydroxyl radical. 
The toxicity of oxygen-derived free radicals arises from the presence of one or more 
unpaired electrons that extract electrons from macromolecules, ultimately inactivating them. 
At high level reactive oxygene species induce the oxidation of protein, lipid and 
DNA/RNA, increase the leakage of lactate dehydrogenase and reduce the intracellular 
glutathione level. In neuron and in neuronal cell lines (e.g., PC12) accumulation of H2O2 can 
activate the stress sensor JNK/p38 MAPK pathway (Cho et al., 2008) and eventually the 
tumour suppressor gene p53 (Reuter et al., 2010). A source of the hydroxyl radical is also the 
nitrogen-derived radical, nitric oxide, which can combine with superoxide to produce 
peroxynitrite. Peroxynitrite is capable of directly damaging proteins, lipids, and nucleic 
acids and can generate hydroxyl radicals and NO2 in PC12 cells (Pytlowany et al., 2008; 
Shacka et al., 2006). 
In the last decade increasing attention has been focused on alternative signaling pathways 
leading to cell death, as for instance autophagy and parthanatos. In PC12 cells serum or 
growth factors withdrawal can lead to autophagy instead of apoptosis. Autophagy is an 
evolutionarily conserved lysosomal pathway involved in the turnover of long-lived proteins 
and organelles. Functions of autophagy include: remodeling during development and 
differentiation and elimination of unwanted or damaged organelles and molecules. These 
functions are important for maintenance of cytoplasmic homeostasis. Autophagy can be 
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stimulated in response to different situations of stress, such as starvation, changes in cell 
volume, oxidative stress, accumulation of misfolded proteins, hormonal signaling, 
irradiation, xenobiotic or the pro-apoptotic ligand TRAIL treatment. Following the 
induction of autophagy, autophagic vesicles or autophagosomes are formed through the 
assembly and expansion of double-layered, membrane-bound structures of endoplasmic 
reticulum around whole organelles and isolated proteins. The autophagosome encapsulates 
the cytosolic materials, then docks and fuses with lysosomes or other vacuoles, causing 
degradation of the autophagosomal contents. At the molecular level, the signaling pathway 
that leads to autophagy seem to involve the activities of PI3K and mTOR. In PC12 cells, two 
key autophagy genes, ATG7 and beclin 1, have been recently reported to be involved in this 
non-apoptotic death pathway.  
In traumatic brain injury, excitotoxicity, ischemia, and, in many neurodegenerative 
disorders, PARP-1 activation is an early biochemical cell death event. PARP-1 activation 
leads to a unique form of cell death that is in large part mediated via accumulation of PAR 
and nuclear translocation of AIF from mitochondria that induces large-scale DNA 
fragmentation, chromatin condensation, and cell death. PARP-1-dependent cell death is 
caspase independent as caspase inhibitors are ineffective in limiting it and is termed 
parthanatos. In several neuronal model including PC12, parthanatos has been recently 
studied together with its players (Kondo et al., 2010). The intriguing aspect emerging from 
parthanatos is that the nuclear–mitochondrial cross talk with PAR is important player for 
cell death initiation. Indeed, PAR is generated mainly in the nucleus and localizes to cytosol 
and interacts with mitochondria to induce cell death. Parthanatos is a unique form of cell 
death that occurs across organ systems, which is primarily mediated by toxic accumulation 
of PAR in cytosol from overactivation of PARP-1. Although the mechanism of parthanatos 
includes PAR as a signaling molecule to induce AIF release from mitochondria, the 
mechanistic aspects of the AIF-releasing capacity of PAR remain unclear.  
Although programmed cell death is well accepted as a common homeostatic property of all 
tissues, its frequency is underestimated. Dying cells are rarely observed in normal tissues, 
thus illustrating the effectiveness of the clearance process. Indeed, a key event in the 
apoptosis programme is the swift clearance and phagocytosis of dying cells by wandering or 
resident scavengers and neighbouring phagocytes (Gregory & Pound, 2011). However, the 
vast majority of research on apoptosis has focused on the stages leading up to the clearance 
phase, or indeed has been carried out under artificial conditions lacking the clearance phase 
such as in model populations of non-phagocytic cells in vitro. In normal or pathological 
tissues, apoptotic cells are invariably found in association with macrophages and 
neighbouring cells of various lineages which actively engage in the apoptotic cell clearance 
process. In the developing brain, multipotential cells phagocytose their dying neighbours 
prior to the appearance of the specialist phagocytes of the nervous system, the microglia. 
Furthermore, in tumours, clearance of apoptotic cells is mediated by macrophages, non-
macrophage stromal cells, and tumour cells themselves. These features need to be taken into 
account in elucidating the finer mechanisms of apoptotic cell death, as for instance those 
underlying the interactions of the apoptotic cell with its environment. 
3.2 Factors and compounds involved in apoptosis regulation  
Much current work with in vitro systems for (neuro)cytotoxicity/(neuro)cytoprotection 
testing lies in maximizing their potential for yelding valid mechanistic response. Among the 
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advantages of in vitro models, i.e., PC12 cells, are the option to study a single cell type of 
interest in the absence of other cell types, ease of direct observation and measurement of 
cellular responses to chemicals, a defined extracellular environment, and direct interactions 
of the chemical with test cells. Until recently, it was thought that cytotoxic/cytoprotective 
drugs affected target cells directly by interfering with some life-maintaining function. 
However, of late, it has been shown that exposure to several drugs with disparate 
mechanisms of action modulates apoptosis in both pathological and normal cells. 
Among ubiquitous toxic environmental contaminants, cadmium, manganese, copper (an 
essential trace element contained in common foods), methylmercury, and bisphenol A may 
induce apoptosis in PC12 cells. Recently, it has been demonstrated that melamine, which has 
been used in milk powder as an additive to raise the measured protein content, and 
monocrotophos, a widely used organophosphate pesticide, also displayed apoptotic effects. 
In contrast, the phenol tert-butylhydroquinone, a synthetic food grade antioxidant, that is 
used to stabilize foods, fats and vegetable oils aganist oxidative damage, prevents apoptosis 
in differentiated PC12 cells. Similar effects are achieved by pyrroloquinoline quinone, a 
novel redox cofactor which exists in various foods. 
Current evidence in the literature supports a cytoprotective role of NGF in PC12 cells (see 
also above) such as against apoptosis induced by TNF┙. The transition of cells from a 
proliferative to a differentiated, quiescent stage is associated with acquisition of a highly 
reduced intracellular environment, which confers cytoprotection against oxidative 
challenge. The reason as to why PC12 cells acquire a reduced intracellular status during 
differentiation is probably due to the fact that neuronal cells are highly oxidative, which 
could render cells vulnerable to reactive oxygene species-induced injury. Therefore, 
adaptation of differentiated neuron-like PC12 cells to a reduced environment and a higher 
expression of redox enzymes would permit cells to function optimally under oxidizing 
conditions, and increase the likelihood for survival against oxidative challenges. 
Oxidative stress has been widely believed to be an important pathogenetic mechanism of 
neuronal apoptosis, occurring in different brain diseases, as for instance Alzheimer disease 
and Parkinson’s disease. It is thus not surprising that neuron-like PC12 cells are extensively 
used in the study of brain disorders. In this respect, amyloid ┚ peptide, dopamine, 6-
hydroxydopamine, and MPP+ are shown to induce apoptosis in PC12 cells. Amyloid ┚ 
peptide toxicity is a well-established pathway of neuronal cell death which play a role in 
Alzheimer’s disease. In addition, 6-hydroxydopamine is a neurotoxin used by scientists to 
selectively kill dopaminergic and noradrenergic neurons. The main use for 6-
hydroxydopamine in scientific research is to induce Parkinsonism, as well as the neurotoxin 
1-methyl-4-phenylpyridinium. Similarly, dieldrin, which may selectively destroy 
dopaminergic neurons, induces apoptosis in PC12 cells. It is a chlorinated hydrocarbon 
originally produced as an insecticide and has been reported to be one of the environmental 
factors correlated with Parkinson’s disease. The effects of some of these substances can be 
reverted by different anti-apoptotic compounds. Among them, some novel substituted 
bisphenol A derivatives, bone morphogenetic protein 7, and galantamine have protective 
effects against amyloid ┚ peptide-induced PC12 apoptosis. Galantamine is an 
acetylcholinesterase inhibitor widely used for patients with Alzheimer’s disease. In 
addition, granulocyte-macrophage colony-stimulating factor, a hematopoietic cytokine that 
has the potential for clinical application, significantly reduces 1-methyl-4-
phenylpyridinium-induced PC12 apoptosis. Some interesting results may also account from 
gene therapy strategies. For instance, the anti-apoptotic herpes simplex virus type 2 gene 
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ICP10PK has been reported to protect neuronally differentiated PC12 cells from apoptosis 
death caused by MPP+. Finally, other substances which display somewhat activity in brain 
have been shown to modulate apoptosis in PC12 cells: the opioid morphine induces 
apoptosis, while lithium chloride, the antipsychotics citalopram and trifluoperazine, and 
serotonin exert opposite effects. 
 
name description source effect 
hydroxyecdysone ecdysteroid hormone different plant sources anti-apoptotic 
apocynum leaf flavonoid extract Apocynum venetum anti-apoptotic 
aucubin iridoid glycoside 
Aucuba japonica and other 
plant sources 
anti-apoptotic 
camptothecin alkaloid Camptotheca accuminata apoptotic 
cEppt  cinnamon extract anti-apoptotic 
decursin coumarin Angelica gigas anti-apoptotic 
euplotin C sesquiterpenoid 
ciliate protist Euplotes 
crassus 
apoptotic 
gomesin peptide 
tarantula Acanthoscurria 
gomesiana 
apoptotic 
ginsenoside Rb1 steroid glycoside ginseng (Panax) anti-apoptotic 
icariin flavonoid Epimedium brevicornum anti-apoptotic 
isochaihulactone lignan compound Bupleurum scorzonerifolium anti-apoptotic 
isoflavones 
poliphenolic 
compounds 
Fabaceae anti-apoptotic 
kaempferol flavonoid different plant sources anti-apoptotic 
lactacystin cyclic amide bacteria Streptomyces apoptotic 
MAM naphthoquinone Polygonum cuspidatum anti-apoptotic 
olive leaf  olive tree (Olea europaea) anti-apoptotic 
paclitaxel/docetaxel taxanes Taxus brevifolia, baccata apoptotic 
paeoniflorin monoterpene glycoside Paeonia albiflora anti-apoptotic 
puerarin isoflavone C-glycoside Pueraria lobota anti-apoptotic 
quercetin flavonoid 
Quercum and other plant 
sources 
anti-apoptotic 
salidroside 
phenylpropanoid 
glycoside 
Rhodiola rosea anti-apoptotic 
schisandrin B/C lignans Schisandra chinensis anti-apoptotic 
SG-168 acetal skeleton Dendrobium nobile anti-apoptotic 
silibinin flavonolignan 
milk thistle (Silybum 
arianum)
anti-apoptotic 
tetrahydroxystilbene 
glucoside 
monomer of stilbene Polygonum multiflorum anti-apoptotic 
trans resveratrol phenol grapes anti-apoptotic 
vincristine/vinblastine vinca alkaloids Catharanthus roseus apoptotic 
xyloketals  mangrove fungus Xylaria anti-apoptotic 
Table 1. Examples of natural products identified as modulators of PC12 cell apoptosis 
Many commercialized drugs have been obtained by the synthesis of new compounds. On 
the other hand, an alternative source of drugs is natural products (and the structural 
modification of natural products), which frequently seem to be more effective and/or less 
toxic. A natural product is a chemical compound or substance produced by a living 
organism - found in nature that usually has a pharmacological or biological activity. Nature 
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is an attractive source of new therapeutic candidate compounds (da Rocha et al., 2001) as a 
tremendous chemical diversity is found in millions of species of plants, animals, marine 
organisms and microorganisms. For many living organisms, this chemical diversity reflects 
the impact of evolution in the selection and conservation of self-defense mechanisms that 
represent the strategies employed to repel or destroy predators. However, the development 
of novel agents from natural sources presents obstacles that are not usually met when one 
deals with synthetic compounds. For instance, there may be difficulties in accessing the 
source of the samples, obtaining appropriate amounts of the sample, identification and 
isolation of the active compound in the sample, and problems in synthesizing the necessary 
amounts of the compound of interest. These problems became evident when the tubulin-
interacting agent taxol was introduced in clinical use. Antitumour activity was observed in 
various in vitro systems, including PC12 cells, and in vivo tumours. It took some years to 
develop a semi-synthetic analog which is derived from a renewable source. Currently, total 
synthesis has been achieved drug supply is no longer a problem. Among their various 
biological activities, natural products can modulate apoptosis signaling pathways (Fulda, 
2010). In PC12 cells, many scientific papers report pro-apoptotic and anti-apoptotic activity 
of different natural products, isolated mostly from plant sources, others from microbes, 
fungi and different marine organisms. Table 1 shows some examples of agents derived from 
natural sources which have been studied in 2010-2011 as modulators of PC12 cell apoptosis. 
Some “classical” apoptotic modulators have been also indicated.  
In many studies, PC12 cell models to study apoptotic mechanisms/modulations have been 
obtained with the use of lipopolysaccharide, the major component of the outer membrane of 
Gram-negative bacteria, or ethanol. Apoptosis can be also induced by depletion of serum 
and NGF from the culture medium. Other factors may include glucose deprivation, a high 
oxygen atmosphere or oxidative agents as for instance hydrogen peroxide, peroxynitrite, the 
lipid peroxidation product 4-hydroxynonenal, and 7-ketocholesterol, the major oxidation 
product of cholesterol found in human atherosclerotic plaque. Moreover, many other 
organic/endogenous compounds, like parathyroid hormone(1-34), corticosterone, and 
ceramide exert pro-apoptotic effects in PC12 cells. Interestingly, taurine, a free amino acid 
with antioxidant activity present in high concentrations in a variety of organs of 
mammalians, protects cells from apoptosis induced by hydrogen peroxide. In addition, 
heparin-binding epidermal growth factor-like growth factor is a member of the epidermal 
growth factor family that is expressed in many cell types. In PC12 cells, its protective effects 
against apoptosis induced by oxygen and glucose deprivation has been reported. Recently, 
different synthetic compounds have been shown to display cytoprotective behaviours 
against oxidative stress, among them folacin C60, the isothiocyanates 3H-1, 2-dithiole-3-
thione, fasudil mesylate, the new 1,2,4-triazine, , 3-butyl-6-bromo-1(3H)-isobenzofuranon 
and a new synthetic 1,2-diaryl oxazine derivative, 2-ethoxy-4,5-diphenyl-1,3-oxazine-6-one. 
In this line, the soluble guanylyl cyclase activator YC-1, which inhibits the hypoxia-
inducible factor 1, and edaravone, a potent free radical scavenger in clinical use, 
significantly antagonize the PC12 apoptosis induced by glutamate or prion protein peptides, 
respectively. 
The ability to induce apoptosis in many tumoural systems, including PC12 cells, has been 
reported as key property for different chemotherapeutic drugs or substances with potential 
therapeutic activity. For instance, the chemotherapeutic drugs fluorouracil, paclitaxel, and 
enediynes are potent inducers of apoptosis in PC12 cells. Also, therapeutic concentrations of 
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cisplatin may cause a hybrid type of cell death characterized by concurrent apoptosis and 
necrosis in the same individual cells. Interestingly, I-387, a novel synthetic compound that 
inhibits tubulin action and exhibits potent antitumour activity in various preclinical models, 
has been shown to display apoptotic activity in different systems, including PC12 cells, 
suggesting that it may represent a new antimitotic agent for management of various 
malignancies. It is also of interest the fact that human pheochromocytomas express high 
levels of the receptor subtype 2 for the neuropeptide somatostatin. Recently, it has been 
demonstrated that somatostatin agonists as well as somatostatin cytotoxic compounds may 
induce PC12 cell apoptosis, although no data are available on pheochromocytomas in vivo 
(Ziegler et al., 2009). Generally, the implications of such apoptotic studies in oncology are 
puzzling. Indeed, often forgotten in the biology of tumours, cell loss in malignant disease is 
a very significant component of tumour dynamics. One may assume that enhanced 
apoptosis will retard tumour growth and hence indicate a favourable prognosis compared 
with tumours showing a low apoptotic activity. However, also the opposite seems to be 
true: apoptosis is a common process in high-grade malignancy, with high apoptosis indices 
generally reflecting poor prognosis. Clearly, the balance between cell birth and cell death 
must favour the former in order for a tumour to grow but, given the properties of apoptotic 
cells and their capacity to affect their microenvironments and host immune systems, it 
seems likely that the cell-death programme also provides oncogenic drive (Gregory & 
Pound, 2011). In this respect, the implications that the homeostatic properties of apoptosis 
can be hijacked as a sinister, facilitatory mechanism for malignant disease development and 
progression are clear and the programme may be regarded as ‘altruistic’ in this context: loss 
of a fraction of the growing population for the greater good of the whole (but detriment of 
the host). 
4. Conclusion 
From a general point of view, dysregulation of apoptosis is associated with many 
pathologic conditions and may even be central in the pathogenesis of many diseases 
(Zangemeister-Wittke & Simon, 2001). Apoptosis research is rapidly proceeding making 
it difficult to keep track of the constant stream of newly identified proteins and 
molecular interactions involved in cell death regulation. However, there is a general 
agreement that the suppression, overexpression or mutation of a number of factors 
which orchestrate the apoptotic process are associated with disease. As outlined above, 
the study of apoptosis mechanisms in PC12 cells represent one application currently of 
great potential interest.  
In pheochromocytomas as well as in the majority of malignancy there is a need of novel 
compounds which may act as potent and selective apoptotic modulators. In the clinical 
practice of benign pheochromocytoma, the most common treatment is surgical removal of 
the entire affected adrenal gland. On the other hand, there is currently no effective 
treatment for malignant pheochromocytoma. Radiotherapy provides benefit in some 
patients with malignant pheochromocytoma. Chemotherapy with cyclophosphamide, 
vincristine, and dacarbazine may produce partial remission, but again is not curative. In 
this respect, much work is still to do in order to exploit new chemical space for drug-like 
molecules.  
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5. Abbreviations 
AIF, apoptosis inducing factor; Apaf-1, apoptosis protease-activating factor 1; BDNF, brain-
derived neurotrophic factor; ERK, extracellular-regulated kinases; FADD, Fas-associated 
death domain; FasL, Fas Ligand; FoxO, forkhead box O; GTP, guanosine triphosphate; JNK, 
Jun N-terminal Kinase; MAPK, mitogen-activated protein kinases; MEK, MAPK kinases; 
MPP+, 1-methyl-4-phenylpyridinium; mTOR, mammalian target of rapamycin; mTORC1, 
mTOR complex 1; NGF, Nerve Growth Factor; NMDA, N-Methyl-D-aspartic acid; NT, 
neurotrophin; PARP-1, poly (ADP-ribose) polymerase-1; PI3K, phosphatidylinositol 3-
kinases; TNF, Tumour Necrosis Factor; Trk, transmembrane tyrosine kinase proteins. 
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